Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Court: Wyeth can be sued over thimerosal
The Georgia Supreme Court has allowed an Atlanta couple to pursue a suit that attempts to prove a Wyeth vaccine containing thimerosal caused their son's disability. The state's high court upheld a first-of-its-kind ruling by an appellate court that had drawn fierce opposition from the vaccine industry; Wyeth says it will appeal the decision to the U.S. Supreme Court. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
